Mode
Text Size
Log in / Sign up

Inflammatory cytokines correlate with vestibular-oculomotor dysfunction in Fabry disease patientsCould a blood marker signal eye movement trouble in Fabry disease?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that inflammatory cytokines correlate with vestibular-oculomotor dysfunction in Fabry disease, but evidence is observational and not causal.

This was a prospective observational cohort study of 40 patients with Fabry disease. The study measured inflammatory cytokines and conducted vestibular-oculomotor examinations to explore their relationship with dysfunction. The comparator was patients without specific abnormalities or with normal function.

Patients with prolonged saccade latency had significantly higher TNF-β levels (1.61 ± 0.38 vs 1.14 ± 0.39, p=0.001). TNF-β was also higher in patients with hypometria (1.46 ± 0.39 vs 1.18 ± 0.48, p=0.043). Average saccade latency positively correlated with TNF-β (r=0.378, p=0.021), while saccadic accuracy negatively correlated (r=-0.333, p=0.044).

IL-12p70 was elevated in patients with defective pursuit (1.63 ± 0.20 vs 1.21 ± 0.54, p=0.040). IL-2 (3.40 ± 1.00 vs 2.13 ± 0.91, p=0.007), IL-17A (6.42 ± 3.59 vs 3.05 ± 2.13, p=0.021), and TNF-β (1.55 ± 0.41 vs 1.21 ± 0.37, p=0.030) were significantly elevated in patients with vestibulo-oculomotor dysfunction versus those with normal function.

Safety and tolerability were not reported. Key limitations include a small sample size, only 22 of 40 patients receiving vestibulo-oculomotor examination, and no healthy control group. The study reports associations, not causation. Practice relevance is not established.

If you have Fabry disease, you might wonder what's behind eye movement problems that can affect daily life. This small study looked at 40 patients and found that higher levels of inflammation markers in the blood were linked to specific eye movement issues. For example, patients with slower eye jumps had higher TNF-β levels, and those with less accurate eye movements also showed elevated TNF-β. Other markers like IL-2 and IL-17A were higher in patients with broader eye movement dysfunction.

The study involved Fabry disease patients, but only 22 of the 40 had detailed eye exams. There was no healthy control group, and the sample was small, so the findings are early and uncertain. No safety issues were reported, but the study can't prove that inflammation causes these eye problems—it only shows an association.

In short, this research hints at a possible link between inflammation and eye movement trouble in Fabry disease, but much more work is needed to understand what it really means for patients.

What this means for you:
Inflammation markers may link to eye movement issues in Fabry disease, but it's not proven to cause them.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectivesVestibular and oculomotor abnormalities have been widely identified in Fabry disease (FD), with inflammation potentially playing an important role. We aim to investigate the expression of inflammatory cytokines (ICs) in FD patients and their relationship with the vestibular/oculomotor dysfunctions.MethodsThis prospective observational study enrolled 40 FD patients. All 40 patients underwent the visuo-oculomotor examination, and 22 of them received the vestibulo-oculomotor examination. Plasma concentrations of 14 ICs were detected, including interferon-γ, interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17A, IL-17F, IL-22, tumor necrosis factor (TNF)-α, and TNF-β. Statistical analyses were made between different subgroups of patients.Results(1) In the visuo-oculomotor examination, TNF-β was significantly higher in patients with prolonged saccade latency (1.61 ± 0.38 VS 1.14 ± 0.39, p=0.001) and hypometria (1.46 ± 0.39 VS 1.18 ± 0.48, p=0.043) than in patients without those abnormalities. The average saccade latency was positively correlated with the level of TNF-β (r=0.378, p=0.021), while the average saccadic accuracy was negatively correlated with the level of TNF-β (r=-0.333, p=0.044). IL-12p70 was significantly elevated in patients with defective pursuit compared to patients with normal pursuit (1.63 ± 0.20 VS 1.21 ± 0.54, p=0.040). (2) In the patients with vestibulo-oculomotor dysfunction, the plasma levels of IL-2 (3.40 ± 1.00 VS 2.13 ± 0.91, p=0.007), IL-17A (6.42 ± 3.59 VS 3.05 ± 2.13, p=0.021) and TNF-β (1.55 ± 0.41 VS 1.21 ± 0.37, p=0.030) were significantly elevated compared to the patients with normal vestibulo-oculomotor function.ConclusionsInflammation-mediated pathological mechanism, especially TNF-β-related pathways, is associated to both central and peripheral vestibular dysfunction in FD patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.